Aspen Pharmacare Holdings (APN.JO) Részvény Árfolyam
Aspen Pharmacare Holdings Árfolyam
Az elmúlt 19 évben a(z) Aspen Pharmacare Holdings árbevétele évi 12,0%-kal nőtt, és elérte a 34,87 Md ZAR-t. Az egy részvényre jutó eredmény évi 6,1%-kal nőtt az elmúlt 19 évben. A(z) Aspen Pharmacare Holdings esetében a 7,6%-os nettó árrés csökkent a néhány évvel ezelőtti 16,8%-hoz képest. A mai áron az osztalékhozam nagyjából 1,28%. A kifizetési ráta a nyereség körülbelül 28%-a. Az osztalék évi 6,1%-kal nőtt az elmúlt 19 évben. A(z) Aspen Pharmacare Holdings 12 hónapos konszenzusos célára 117,30 ZAR, körülbelül alatt az árfolyamot 28,7%-kal. 10 elemzőből 0 vételt javasol — az összesített konszenzus Tartás.
Aspen Pharmacare Holdings részvényár
Ezeket az adatokat az Eulerpool API-n keresztül
100 000 kérés/hó ingyen · nincs bankkártya
Aspen Pharmacare Holdings üzleti modell és részvényelemzés
Gyakran feltett kérdések a Aspen Pharmacare Holdings részvényről
The business model of Aspen Pharmacare Holdings Ltd is focused on the manufacturing and marketing of pharmaceutical and healthcare products. Aspen Pharmacare is a leading global supplier of branded and generic pharmaceuticals, as well as infant nutritionals and consumer healthcare products. With a diverse portfolio of products, the company operates across multiple therapeutic areas including anaesthetics, thrombosis, oncology, and respiratory. Aspen Pharmacare also engages in extensive research and development activities to drive innovation within the pharmaceutical industry. Its commitment to quality and affordability ensures the availability of essential medicines to a wide range of markets worldwide.
Aspen Pharmacare Holdings Ltd is primarily active in the pharmaceutical industry.
The main competitors of Aspen Pharmacare Holdings Ltd in the market are Teva Pharmaceutical Industries Ltd, Mylan N.V., and Sun Pharmaceutical Industries Ltd.
Aspen Pharmacare Holdings Ltd, commonly known as Aspen, is a leading global pharmaceutical company with a rich history and strong background. Founded in 1850 and headquartered in Durban, South Africa, Aspen has grown into a reputable player in the healthcare industry. The company specializes in the manufacturing and distribution of both branded and generic pharmaceutical products across various therapeutic areas. With a diversified portfolio, Aspen operates in more than 150 countries, serving patients and healthcare professionals worldwide. Over the years, Aspen has made strategic acquisitions and formed partnerships to expand its product offerings and global reach. With a commitment to improving patient lives, Aspen continues to drive innovation and deliver quality healthcare solutions globally.
Aspen Pharmacare Holdings Ltd, a leading pharmaceutical company, has achieved several significant milestones. Over the years, the company has expanded its global presence and diversified its product portfolio. It has successfully acquired and integrated multiple companies, enhancing its market reach and capabilities. Aspen Pharmacare has also developed and launched innovative medicines, contributing to advancements in healthcare. The company has received numerous industry awards and recognition, further highlighting its commitment to excellence. With a strong focus on research and development, Aspen Pharmacare continues to make substantial contributions to the healthcare industry, delivering high-quality solutions to patients worldwide.
Aspen Pharmacare Holdings Ltd is primarily present in various countries and regions worldwide. Some of the key markets where the company operates include South Africa, where it is headquartered, as well as other African countries such as Kenya, Nigeria, and Ethiopia. Additionally, Aspen Pharmacare has a significant presence in Latin American countries including Brazil and Mexico. The company has also expanded its operations into Europe, with a focus on countries like Germany, Spain, Italy, and the United Kingdom. Furthermore, Aspen Pharmacare has a presence in the Asia-Pacific region, including Australia, China, and India.
Aspen Pharmacare Holdings Ltd represents a strong set of values and a clear corporate philosophy. The company aims to provide affordable medicines of high quality to people around the world, thus improving their health and well-being. Aspen Pharmacare values integrity, innovation, and accountability in all aspects of its operations. It focuses on sustainable growth and strategic partnerships to expand its global presence and reach. Aspen Pharmacare is committed to providing access to essential healthcare solutions and ensuring patient safety. With its dedicated workforce and commitment to excellence, Aspen Pharmacare continues to make a positive impact in the pharmaceutical industry.
Az elemzők jelenleg 120,02 ZAR átlagos célárat adnak a Aspen Pharmacare Holdings részvényre (medián: 117,30 ZAR), ami -27,0 % a legutóbbi árhoz képest. A konszenzus 10 elemzői minősítésen alapul.
10 elemző értékeli jelenleg a Aspen Pharmacare Holdings részvényt: 0 vételt, 6 tartást és 4 eladást javasol.
Az aktuális árfolyamon a Aspen Pharmacare Holdings részvény 8,84 EUR (164,45 ZAR).
A Aspen Pharmacare Holdings részvény (APN.JO) 5 tőzsdén jegyzett, többek között: JSE (Johannesburg) (APN.JO), Frankfurt (LDZA.F), München (LDZA.MU), Düsseldorf (LDZA.DU).
Aspen Pharmacare Holdings Ltd is an international pharmaceutical company based in South Africa. The company specializes in the production and distribution of pharmaceuticals, biopharmaceuticals, and active ingredients. It is one of the largest manufacturers of generics in Africa. The company's business model is characterized by intensive R&D work and a strong presence in Africa. It produces a wide range of pharmaceutical products for various fields such as psychiatry, oncology, gastroenterology, and pain therapy. Aspen is also a significant provider of veterinary medicines. One of the key aspects of its business model is the production of generics, offering cost-effective alternatives to branded products. This allows Aspen to establish a strong presence and achieve high market penetration in markets with limited investment requirements. The company has expanded its business in Europe and Asia, in addition to its strong presence in Africa. This geographical diversification allows Aspen to reach a broad customer base and minimize risks. Besides its products, Aspen also offers tailored services such as shipping, storage, and logistics management to ensure fast and efficient delivery to customers. The company has also expanded its presence in biopharmaceuticals through the acquisition of ThromboGenics in 2013, making it a leading provider of platelet activating factors. Aspen is committed to social responsibility and has initiated various initiatives to improve access to affordable medical products in Africa. Overall, Aspen Pharmacare Holdings Ltd's business model is based on its wide range of products and services, strategic focus on the African market, and effective implementation of its strategy, which has made it one of the largest and fastest-growing pharmaceutical companies in Africa.
A bevétele Aspen Pharmacare Holdings 34,87 Md ZAR. Ez az érték az aktuális pénzügyi adatokon alapul, és a vállalat üzleti teljesítményét tükrözi.
A nyeresége Aspen Pharmacare Holdings 2,65 Md ZAR. A nettó nyereség a vállalat nyereségességét tükrözi az összes költség levonása után.
A Aspen Pharmacare Holdings ár/nyereség mutatója (P/E) jelenleg 27,55. A P/E mutató az aktuális részvényárat az egy részvényre jutó nyereséggel hasonlítja össze, és segít a befektetőknek a Aspen Pharmacare Holdings részvény értékelésének megértésében.
A Aspen Pharmacare Holdings ár/értékesítés mutatója (P/S) jelenleg 2,09. A P/S mutató a piaci kapitalizációt az éves bevételhez hasonlítja, és a Aspen Pharmacare Holdings részvény értékelési mérőszámaként szolgál.
Az Eulerpool minőségi pontszáma a Aspen Pharmacare Holdings számára 1/10.
A Aspen Pharmacare Holdings ISIN-je ZAE000066692. Az ISIN (International Securities Identification Number) a nemzetközi securities azonosító.
A Aspen Pharmacare Holdings WKN-je A0ET80. A WKN (Wertpapierkennnummer) egy hatjegyű német értékpapír-azonosító szám.
A Aspen Pharmacare Holdings ticker-e APN.JO. A ticker szimbólum a Aspen Pharmacare Holdings részvény tőzsdei kereskedésénél használatos.
Aspen Pharmacare Holdings részvény
Aspen Pharmacare Holdings Peer Group
Aspen Pharmacare Holdings Tőzsdei rövidítés
Aspen Pharmacare Holdings FIGI
A Aspen Pharmacare Holdings összes alapfundamentuma és mélyreható elemzése
A Aspen Pharmacare Holdings részvény Eulerpool-elemzése olyan fontos pénzügyi mutatókat tartalmaz, mint a bevétel, nyereség, P/E arány, P/S arány, EBIT, valamint információk az osztalékról. Vizsgáljuk a részvények, piaci kapitalizáció, adósság, saját tőke és kötelezettségek vonatkozásait is Aspen Pharmacare Holdings. Ha részletesebb információt keres ezekről a témákról, részletes elemzéseket kínálunk az aloldalainkon.